In this issue, we present another installment of our quarterly review of dealmaking—for April-June 2006. Our data comes from Windhover's Strategic Intelligence Systems, which covers deal activity within the pharmaceutical/biotechnology, medical device, and in vitro diagnostics industries.
The pace of pharmaceutical IPOs picked up in the quarter, with twelve deals closing compared to eight in the first quarter, though the majority were done on European exchanges (just...